Clinical trial · Observational
Establishment of Tongue Image Database and Machine Learning Model for Malignant Tumors Diagnosis
A Multi-center Observational Clinical Study Observing the Differences of Tongue Images Between Patients With Malignant Tumors and Healthy People
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The tongue images of malignant tumors and corresponding healthy people will be collected to establish the tongue image database. Deep learning will be carried out by computer and artificial intelligence to construct the early screening, diagnosis, prognosis and prognosis model of various malignant tumors based on tongue image for the diagnosis and treatment of malignant tumors.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Malignant Tumor | Malignant Neoplasm | ALIAS | 0.90 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Tongue images, coating on the tongue and clinical data of patients with malignant tumors and healthy people will be collected. | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- label
- Patients with malignant tumors and healthy people
- description
- Tongue images, coating on the tongue and clinical data of patients with malignant tumors and healthy people will be collected.
- interventionNames
- Other: Tongue images, coating on the tongue and clinical data of patients with malignant tumors and healthy people will be collected.
Primary outcomes (2)
- measure
- The differences of tongue images between patients with malignant tumors and healthy people.
- timeFrame
- 1 year
- measure
- Overall Survival (OS)
- timeFrame
- 3 years
Secondary outcomes (1)
- measure
- Disease free survival（DFS）
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
- Maximum age
- 80 Years
Show eligibility criteria text
Inclusion Criteria: * 18≤age≤80 * Histologically or cytologically confirmed malignant tumor * No prior chemotherapy, radiotherapy, biotherapy, immunotherapy or other anti-tumor treatment for malignant tumor * Subject volunteers to join the study, Signs informed consent, has good compliance and can cooperate with follow-up Exclusion Criteria: * Two or more kinds of malignant tumors at the same time * Malignant tumor that has been treated by chemotherapy, radiotherapy, biotherapy, immunotherapy or other anti-tumor therapy * Subjects who had other factors that might force them to terminate the research ahead of time, such as the development of other severe disease (including mental disease) that required combined treatment, seriously abnormal laboratory examination value, and family or social factors that might affect the subject safety or experimental data collection, as judged by the researchers
References
Publications (0)
Data not yet available